Dr Anne Peters, of the Keck School of Medicine of the University of Southern California, reports on the latest research on insulin therapy in adults with type 2 diabetes, presented at the European ...

HAMBURG, Germany -- Adding weekly tirzepatide (Mounjaro) to basal insulin reduced HbA1c in patients with poorly controlled type 2 diabetes compared with adding three-times-daily insulin lispro, the ...

Share on Pinterest Mounjaro appears to be a safe and effective adjunct therapy to slow-release insulin for treating uncontrolled diabetes. Mohammed Al Ali/Shutterstock Tirzepatide, Mounjaro, is ...

Please provide your email address to receive an email when new articles are posted on . Weiner: Is insulin pump therapy recommended for people with type 2 diabetes who require basal-bolus therapy?

“Once-weekly IcoSema achieved noninferior A1c reduction and superiority in change in bodyweight, weekly total insulin dose, and hypoglycemia rates vs daily BBT [basal-bolus therapy], suggesting that ...

(HealthDay News) — For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, ...

Please provide your email address to receive an email when new articles are posted on . The FDA is requesting more information on the manufacturing process and type 1 diabetes indication for ...

Dr. Hirsch answers the question: 'Pros and Cons of Different Insulin Types?' — -- Question:What are the pros and cons of various types of insulins? Answer:I don't think we should think of insulin ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

Ethnicity & Disease, Vol. 27, No. 1, Cardiovascular Disease and Risk Factors (Winter 2017), pp. 45-54 (10 pages) Objective: To evaluate the effectiveness and safety of insulin detemir treatment as add ...

Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin. Dexcom ...

(Reuters Health) - A warning for people who use insulin pens: Not shaking your NPH insulin pen before injecting can result in wide variations in your insulin level and blood sugar control, researchers ...